Evidence map›Paper›PMID 39202410›Full record

ArticleGenes2024

Canine Histiocytic and Hemophagocytic Histiocytic Sarcomas Display

Ya-Ting Yang, Alexander I Engleberg, Ishana Kapoor, Keita Kitagawa, Sara A Hilburger, Tuddow Thaiwong-Nebelung, Vilma Yuzbasiyan-Gurkan

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Genes, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ya-Ting YangDepartment of Microbiology, Genetics and Immunology, Michigan State University, East Lansing, MI 48824, USA.ORCID 0000-0001-8512-5336
Alexander I EnglebergDepartment of Microbiology, Genetics and Immunology, Michigan State University, East Lansing, MI 48824, USA.ORCID 0000-0002-2057-4306
Ishana KapoorDepartment of Microbiology, Genetics and Immunology, Michigan State University, East Lansing, MI 48824, USA.
Keita KitagawaComparative Medicine and Integrative Biology Program, College of Veterinary Medicine, Michigan State University, East Lansing, MI 48824, USA.ORCID 0000-0001-7484-9793
Sara A HilburgerDepartment of Microbiology, Genetics and Immunology, Michigan State University, East Lansing, MI 48824, USA.
Tuddow Thaiwong-NebelungVeterinary Diagnostic Laboratory, College of Veterinary Medicine, Michigan State University, Lansing, MI 48910, USA.
Vilma Yuzbasiyan-GurkanDepartment of Microbiology, Genetics and Immunology, Michigan State University, East Lansing, MI 48824, USA.ORCID 0000-0001-9720-1279

Funding

Berner Garde Foundation and Bernese Mountain Dog Club of America No number given
6 · The paper itself

Abstract

Histiocytic sarcoma (HS) is a rare and highly aggressive cancer in humans and dogs. In dogs, it has a high prevalence in certain breeds, such as Bernese mountain dogs (BMDs) and flat-coated retrievers. Hemophagocytic histiocytic sarcoma (HHS) is a unique form of HS that presents with erythrophagocytosis. Due to its rareness, the study of HHS is very limited, and mutations in canine HHS patients have not been studied to date. In previous work, our research group identified two major

Indexed as

AzetidinesHistiocytic SarcomaMutationPiperidinesProtein Tyrosine Phosphatase, Non-Receptor Type 11Proto-Oncogene Proteins p21(ras)AnimalsCell Line, TumorDog DiseasesDogsProtein Kinase InhibitorsAzetidinescobimetinibPiperidinesProtein Kinase InhibitorsProtein Tyrosine Phosphatase, Non-Receptor Type 11Proto-Oncogene Proteins p21(ras)cancer geneticscobimetinibcomparative oncologyhemophagocytic histiocytic sarcomahistiocytic sarcomaKRASMAPK pathwayMEK inhibitorsmyeloid tumorsPTPN11SHP2

Identifiers

PMID39202410
PMCPMC11353564

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.